133 related articles for article (PubMed ID: 37758047)
21. Bisphenol A Analogues Inhibit Human and Rat 11β-Hydroxysteroid Dehydrogenase 1 Depending on Its Lipophilicity.
Wang H; Sang J; Ji Z; Yu Y; Wang S; Zhu Y; Li H; Wang Y; Zhu Q; Ge R
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446556
[TBL] [Abstract][Full Text] [Related]
22. Direct inhibition of bisphenols on human and rat 11β-hydroxysteroid dehydrogenase 2: Structure-activity relationship and docking analysis.
Zhang B; Wang S; Tang Y; Hu Z; Shi L; Lu J; Li H; Wang Y; Zhu Y; Lin H; Ge RS
Ecotoxicol Environ Saf; 2023 Apr; 254():114715. PubMed ID: 36871355
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a non-estrogenic irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 from 3-substituted-16β-(m-carbamoylbenzyl)-estradiol derivatives.
Maltais R; Ayan D; Trottier A; Barbeau X; Lagüe P; Bouchard JE; Poirier D
J Med Chem; 2014 Jan; 57(1):204-22. PubMed ID: 24328103
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
[TBL] [Abstract][Full Text] [Related]
25. Comparative investigation of the in vitro inhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1.
Herman BE; Szabó J; Bacsa I; Wölfling J; Schneider G; Bálint M; Hetényi C; Mernyák E; Szécsi M
J Enzyme Inhib Med Chem; 2016; 31(sup3):61-69. PubMed ID: 27424610
[TBL] [Abstract][Full Text] [Related]
26. Curcuminoids inhibit human and rat placental 3β-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico docking analysis.
Sang J; Chu J; Zhao X; Quan H; Ji Z; Wang S; Tang Y; Hu Z; Li H; Li L; Ge RS
J Ethnopharmacol; 2023 Apr; 305():116051. PubMed ID: 36572324
[TBL] [Abstract][Full Text] [Related]
27. Bisphenol a alternatives suppress human and rat aromatase activity: QSAR structure-activity relationship and in silico docking analysis.
Xia M; Zheng J; Chen S; Tang Y; Wang S; Ji Z; Hao T; Li H; Li L; Ge RS; Liu Y
Food Chem Toxicol; 2024 Jan; 183():114257. PubMed ID: 38040240
[TBL] [Abstract][Full Text] [Related]
28. Demethoxylation of curcumin enhances its inhibition on human and rat 17β-hydroxysteroid dehydrogenase 3: QSAR structure-activity relationship and in silico docking analysis.
Ji Z; Sang J; Wang H; Xia M; Hao T; Chen L; Lu H; Wang S; Yao M; Li L; Ge RS
Food Chem Toxicol; 2024 Apr; 186():114489. PubMed ID: 38360388
[TBL] [Abstract][Full Text] [Related]
29. Novel estrone mimetics with high 17beta-HSD1 inhibitory activity.
Oster A; Klein T; Werth R; Kruchten P; Bey E; Negri M; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
Bioorg Med Chem; 2010 May; 18(10):3494-505. PubMed ID: 20413314
[TBL] [Abstract][Full Text] [Related]
30. Enhanced inhibition of human and rat aromatase activity by benzene ring substitutions in bisphenol A: QSAR structure-activity relationship and in silico docking analysis.
Zheng J; Chen S; Lu H; Xia M; Wang S; Li X; Li H; Wang Y; Ge RS; Liu Y
J Hazard Mater; 2024 Mar; 465():133252. PubMed ID: 38128231
[TBL] [Abstract][Full Text] [Related]
31. Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.
Marchais-Oberwinkler S; Kruchten P; Frotscher M; Ziegler E; Neugebauer A; Bhoga U; Bey E; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
J Med Chem; 2008 Aug; 51(15):4685-98. PubMed ID: 18630892
[TBL] [Abstract][Full Text] [Related]
32. Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC
Abdelsamie AS; van Koppen CJ; Bey E; Salah M; Börger C; Siebenbürger L; Laschke MW; Menger MD; Frotscher M
Eur J Med Chem; 2017 Feb; 127():944-957. PubMed ID: 27852458
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity study in the class of 6-(3'-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors.
Marchais-Oberwinkler S; Frotscher M; Ziegler E; Werth R; Kruchten P; Messinger J; Thole H; Hartmann RW
Mol Cell Endocrinol; 2009 Mar; 301(1-2):205-11. PubMed ID: 18950679
[TBL] [Abstract][Full Text] [Related]
34. Halogenated bisphenol A derivatives potently inhibit human, rat, and mouse gonadal 3β-hydroxysteroid dehydrogenases: Structure-activity relationship and in silico molecular docking analysis.
Yu Y; Wang M; Chen Y; Pan C; Fei Q; Zhu Y; Li H; Ge RS
Toxicol Lett; 2023 Sep; 386():20-29. PubMed ID: 37683804
[TBL] [Abstract][Full Text] [Related]
35. Bicyclic substituted hydroxyphenylmethanone type inhibitors of 17 β-hydroxysteroid dehydrogenase Type 1 (17 β-HSD1): the role of the bicyclic moiety.
Oster A; Klein T; Henn C; Werth R; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
ChemMedChem; 2011 Mar; 6(3):476-87. PubMed ID: 21337522
[TBL] [Abstract][Full Text] [Related]
36. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
37. Chalcones from plants cause toxicity by inhibiting human and rat 11β-hydroxysteroid dehydrogenase 2: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis.
Lin H; Su M; Wen C; Tang Y; Li H; Wu Y; Ge RS; Li XW; Lin H
Food Chem Toxicol; 2024 Feb; 184():114415. PubMed ID: 38141941
[TBL] [Abstract][Full Text] [Related]
38. Identification of fused 16β,17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors.
Maltais R; Trottier A; Delhomme A; Barbeau X; Lagüe P; Poirier D
Eur J Med Chem; 2015 Mar; 93():470-80. PubMed ID: 25728028
[TBL] [Abstract][Full Text] [Related]
39. Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.
Abdelsamie AS; Bey E; Gargano EM; van Koppen CJ; Empting M; Frotscher M
Eur J Med Chem; 2015 Oct; 103():56-68. PubMed ID: 26322835
[TBL] [Abstract][Full Text] [Related]
40. Secretory expression, purification and functional characterization of 17β-hydroxysteroid dehydrogenase type 1 from mammalian HEK293T cells.
Chen J; Feng W; Zhao Y
Protein Expr Purif; 2017 Sep; 137():52-57. PubMed ID: 28669870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
